Combination of SLT2is and GLP-1RAs offers ‘favourable’ outcomes for treating type 2 diabetes

By Editor
23rd May 2024
Pharmaceutical, Pharmacy Type 2 diabetes
You can sign in with OneKey / OWA to view this content.

Comments (0)